Our study aimed to explore the possible predictive role of GSTM1 and GSTT1 polymorphisms in MTX responsiveness in JIA patients, hypothesising that the deletion variants resulting in decreased enzymatic function boost MTX efficacy in disease control. Here, GSTM1 is linked to juvenile idiopathic arthritis.